All In MedTech

FDA Clearance Tracker · P840008

DORNIER LITHOTRIPTER COMPACT TRANSPORTABLE (DLCT)

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Dec 19, 1984 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Dec 19, 1984

Approved (reclassified)

Time to decision

301 days

Received Feb 22, 1984. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class II

The decision

FDA number
P840008
Device name
DORNIER LITHOTRIPTER COMPACT TRANSPORTABLE (DLCT)
Applicant location
Kennesaw, GA
Received
Feb 22, 1984
Decided
Dec 19, 1984
Decision
Approved (reclassified)
Supplements
63 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class II
Regulation
21 CFR 876.5990

Every decision under product code LNS

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code LNS (Lithotriptor, extracorporeal shock-wave, urological).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Dornier Medtech America, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.